SEARCH

SEARCH BY CITATION

References

  • 1
    Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol1984; 102: 520526.
  • 2
    Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol1984; 102: 527532.
  • 3
    Kristinsson JK. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis. Acta Ophthalmol Scand Suppl1997; 223: 176.
  • 4
    Olafsdóttir E, Stefánsson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol2007; 91: 15991601.
  • 5
    Kohner EM, Stratton IM, Aldington SJ, Holman RR, Mathews DR. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes in the UKPDS (UKPDS 52). Diabet Med2001; 18: 178184.
  • 6
    Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care2011; 34: 13181319.
  • 7
    Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye2007; 21: 465471.
  • 8
    Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet2003; 361: 195200.
  • 9
    Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med2003; 20: 758765.
  • 10
    Klein R, Klein BE, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust N Z J Ophthalmol1990; 18: 1922.
  • 11
    Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL et al.Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. Br Med J2012; 344: e874.
  • 12
    Jones CD, Greenwood RH, Misra A, Bachmann MO. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care2012; 35: 592596.
  • 13
    White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP et al.Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol2008; 126: 17071715.
  • 14
    NIHR Health Technology Assessment Programme. Improving the Value of Screening for Diabetic Macular Oedema using Surrogate Photographic Markers (ISMO) Study. Available at http://www.hta.ac.uk/1703 Last accessed 4 July 2012.
  • 15
    Yeo ST, Edwards RT, Fargher EA, Luzio SD, Thomas RL, Owens DR. Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment. Diabet Med2012; 29: 869877.
  • 16
    Yeo ST, Edwards RT, Luzio SD, Charles JM, Thomas RL, Owens DR. Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening. Diabet Med2012; 29: 878885.